Free Trial
→ Everyone’s watching Nvidia right now. Here’s why I’m excited. (From Timothy Sykes) (Ad)tc pixel Free NLSPW Stock Alerts

NLS Pharmaceutics (NLSPW) SEC Filings & 10K Form

NLS Pharmaceutics logo
$0.02 +0.00 (+18.06%)
As of 09:30 AM Eastern
Compare

Recent NLS Pharmaceutics SEC Filings

Export to Excel
DateFilerForm TypeView
08/06/2025
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/18/2025
4:32 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-4/A
07/17/2025
8:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/01/2025
3:30 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/30/2025
6:31 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/24/2025
3:57 PM		Hafner Ronald (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form SCHEDULE 13D
06/23/2025
4:29 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-4/A
06/16/2025
6:30 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/16/2025
6:32 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
06/10/2025
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/09/2025
7:54 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-4/A
05/01/2025
8:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form NT 20-F
04/15/2025
8:05 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/15/2025
8:07 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
04/14/2025
3:01 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form D
Notice of Exempt Offering of Securities 
03/31/2025
4:23 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-4/A
03/31/2025
9:24 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
03/31/2025
8:29 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/10/2025
8:20 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/10/2025
8:21 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
03/03/2025
5:40 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-4/A
02/27/2025
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/25/2025
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/25/2025
7:02 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
02/14/2025
4:08 PM		Lind Global Fund II LP (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form SCHEDULE 13G/A
02/10/2025
4:43 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
02/10/2025
6:57 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
02/10/2025
6:54 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/05/2025
5:45 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
01/31/2025
6:47 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/31/2025
6:51 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
01/30/2025
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/28/2025
9:46 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
01/28/2025
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/22/2025
4:01 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form D
Notice of Exempt Offering of Securities 
01/16/2025
8:20 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/16/2025
8:22 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
01/14/2025
3:27 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2025
7:04 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2025
7:14 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
01/07/2025
3:30 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
I’d rather trade news like this than gamble on hype (Ad)

Real traders are watching Nvidia’s next move—after U.S. approval to resume chip sales to China. This reversal just triggered a key alert in Tim Sykes’ system… and the setup looks strong.tc pixel

See how this timing-based strategy catches big moves early
12/30/2024
7:52 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/30/2024
7:54 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
12/30/2024
5:13 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-4
Registration statement for securities of certain foreign private issuers issued in certain business combination transactions  
12/23/2024
3:04 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/19/2024
3:23 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K/A
12/19/2024
7:30 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/19/2024
7:32 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
12/17/2024
3:30 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/11/2024
7:30 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/11/2024
7:32 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
12/10/2024
7:30 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K/A
12/03/2024
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/26/2024
11:15 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form EFFECT
11/21/2024
3:01 PM		Hafner Ronald (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form SC 13G/A
11/18/2024
7:30 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/15/2024
4:00 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2024
6:27 PM		Lind Global Fund II LP (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form SC 13G/A
11/08/2024
3:00 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/05/2024
3:30 PM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
11/05/2024
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/04/2024
6:39 PM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
YA II PN, Ltd. (Filed by)
Form SC 13G/A
11/04/2024
5:20 PM		Grisard Felix (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form SC 13G/A
11/04/2024
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/04/2024
7:02 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
10/28/2024
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/23/2024
3:00 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
10/22/2024
3:01 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/21/2024
4:19 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form D
Notice of Exempt Offering of Securities 
10/18/2024
3:31 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/15/2024
12:24 PM		ALPHA CAPITAL ANSTALT (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form SC 13G
10/15/2024
8:09 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/11/2024
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/11/2024
6:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/01/2024
3:01 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/25/2024
7:13 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/19/2024
3:01 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/13/2024
4:01 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:NLSPW) was last updated on 9/2/2025 by MarketBeat.com Staff
From Our Partners
2013 Bitcoin miner reveals his trading system (free)
While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...
Crypto Swap Profits | Sponsoredtc pixel
The day and month stocks are most likely to crash next
Good News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...
Chaikin Analytics | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
America Betrayed
Porter Stansberry says he got one thing wrong—and now millions of Americans could pay the price. After warning...
Porter & Company | Sponsoredtc pixel
6-Figure Target for BTC by 2025
Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...
Crypto 101 Media | Sponsoredtc pixel
NVIDIA's Worst Nightmare?
$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...
The Oxford Club | Sponsoredtc pixel
Crypto Income (almost instantly)
How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...
Awesomely, LLC | Sponsoredtc pixel